Home Portfolio Ecologic® BARRIER

Ecologic® BARRIER

Reducing vulnerability to depression and improving brain function under stress

  • Prevents antibiotic associated diarrhoea
  • Clinically proven in different populations
  • Faster microbiota restoration after antibiotic use
  • Reduction of GI complaints during antibiotic use
  • Recommended by the WGO Global Guidelines
Reflecting on life
Reflecting on life

Medical need

Depression is a global burden, affecting the quality of life of millions of people worldwide. The gut-brain axis plays a crucial role in the communication between the gut and the brain. Specific probiotics could be a promising adjunctive therapy in the management of depressive symptoms.

Clinical outcomes of Ecologic® BARRIER

The premium probiotic formulation Ecologic® BARRIER has been tested in clinical trials. It has shown to:

• Significantly reduce overall cognitive reactivity to sad mood in adults.
• Significantly reduce cognitive reactivity in mild/moderate depressed adults.
• Significantly reduce depressive-like behaviour in rats.
• Significantly increase working memory performance in adults challenged with stress.

Logo Winclove PR0BIOACT Technology

• Stable at room temperature: no refrigeration required.
• Excellent survival of the gastrointestinal tract.
• High viability and metabolic activity of bacteria.

News

News25/04/23

Benefits of Ecologic® Barrier in mood confirmed

Research18/10/22

Ecologic® Barrier shows benefits in athletes

Research29/08/22

Ecologic® Barrier reduces risk-taking behaviour